NUPATHE INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NuPathe Inc. (PATH) Over the Proposed Sale of the...
December 27 2013 - 1:25PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of NuPathe, Inc.
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a
leading national securities firm headquartered in New York City, is
investigating the Board of Directors of NuPathe Inc. (“NuPathe” or
the “Company”) (NasdaqGM: PATH) for potential breaches of fiduciary
duties in connection with their conduct related to the sale of the
Company to Endo Health Solutions (NasdaqGS: ENDP) in a cash deal
valued at approximately $105 million. Under the terms of the
proposed transaction, NuPathe’s stockholders will receive $2.85 for
each share of NuPathe common stock they own, while according to
Yahoo! Finance, at least one financial analyst has set a price
target of $8.00 for NuPathe.
Request more information now by clicking here:
www.faruqilaw.com/PATH. There is no cost or
obligation to you.
The investigation focuses on whether NuPathe’s Board of
Directors breached their fiduciary duties to the Company’s
stockholders by failing to conduct an adequate and fair sales
process prior to agreeing to this proposed transaction, whether and
by how much this proposed transaction undervalues the Company to
the detriment of NuPathe’s shareholders.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, throughout all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients. To keep track of the latest
securities litigation news, follow us on Twitter at
www.twitter.com/MergerActivity or on Facebook at
www.facebook.com/FaruqiLaw.
If you own common stock in NuPathe and wish to obtain additional
information and protect your investments free of charge, please
visit us at www.faruqilaw.com/PATH or contact Juan E. Monteverde,
Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone
at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Faruqi & Faruqi, LLP369 Lexington Avenue, 10th FloorNew
York, NY 10017Attn: Juan E. Monteverde,
Esq.jmonteverde@faruqilaw.comToll Free: 877-247-4292Phone:
212-983-9330
Nupathe Inc. (MM) (NASDAQ:PATH)
Historical Stock Chart
From Dec 2024 to Jan 2025
Nupathe Inc. (MM) (NASDAQ:PATH)
Historical Stock Chart
From Jan 2024 to Jan 2025